Zobrazeno 1 - 10
of 105
pro vyhledávání: '"A. L. Kurenkov"'
Autor:
A. L. Kurenkov
Publikováno v:
Вестник Российского экономического университета имени Г. В. Плеханова, Vol 0, Iss 5, Pp 5-18 (2024)
Digital transformation is an integral part of strategic management at the commercial enterprise, which ensures its sustainable development and competitiveness. Methods of implementing digital transformation keep on changing today. Traditional approac
Externí odkaz:
https://doaj.org/article/2b2d9ff2591549eaaf19748b530c2fec
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 1, Pp 94-101 (2024)
Pain in cerebral palsy (CP) occurs in 30–60% of cases. Pain associated with spasticity (PAS) is one of the most common causes of pain syndrome in cerebral palsy, which is often associated with impairment of the child’s daily life. Recently, more
Externí odkaz:
https://doaj.org/article/ef347cdd3c19449db96c38c5d255c6ff
Autor:
A. L. Kurenkov, L. M. Kuzenkova, B. I. Bursagova, V. V. Chernikov, O. V. Agranovich, L. G. Khachatryan, V. M. Kenis, V. A. Zherebtsova, M. N. Sarzhina, N. D. Odinaeva, A. R. Artemenko, G. A. Popova, E. A. Moroshek, E. E. Tabe, A. A. Nezhelskaya, A. A. Maksimenko, L. Ya. Akhadova, M. V. Indereikin, N. V. Duibanova, L. V. Tikhonova, A. V. Sapogovskiy, Z. M. Gadzhialieva, A. V. Grigorieva, V. S. Perminov, I. D. Fedonyuk, L. M. Kolpakchi, A. Yu. Kursakova, N. A. Tsurina
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 2, Pp 117-125 (2022)
Botulinum therapy for cerebral palsy (CP) is considered not only as one of the effective approaches for the treatment of increased muscle tone and spasticity, but also as a method of excessive salivation correction. The article presents an overview o
Externí odkaz:
https://doaj.org/article/9d0b5cf529ef41c19d59bbf356c0c69c
Autor:
A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 4, Pp 52-59 (2021)
Sialorrhea is a severe medical problem that is difficult to treat, which can lead to serious complications. In almost all cases, chronic sialorrhea is accompanied by a restriction of the child's contacts with peers, socialization difficulties, and a
Externí odkaz:
https://doaj.org/article/738d246fce0c4e50a18745eae0705cea
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 43-49 (2018)
Purpose. Comparative economic analysis of complex rehabilitation of children with cerebral palsy (CP) with and without injections of botulinum neurotoxin type A (Dysport®, BoNT-A). Materials and methods. We clinically followed up 149 children with s
Externí odkaz:
https://doaj.org/article/33cebe3f52cf4d528cc5d3fdd1ac89bf
Autor:
A. L. Kurenkov, O. A. Klochkova, B. I. Bursagova, L. M. Kuzenkova, A. R. Artemenko, I. V. Falkovsky
Publikováno v:
Медицинский совет, Vol 0, Iss 1S, Pp 113-121 (2017)
Injections of botulinum toxin type A (BTA) are regarded as one of the basic methods to treat cerebral palsy (CP). The article discusses issues unique mechanism of action of botulinum toxin type A injections, double sensomotor mechanism of action of t
Externí odkaz:
https://doaj.org/article/d5666562bf6d4bf5b8f4167125496e53
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 7, Iss 4, Pp 20-26 (2017)
Carpal tunnel syndrome (CTS) is a clinical condition with sensoryand motor manifestations related to median nerve (MN)compression at the wrist level. The goal of this study was tocompare two diagnostics methods, electromyography (EMG)and ultrasound (
Externí odkaz:
https://doaj.org/article/3f8cbb1c068f47358a2e8600de4fb61c
Autor:
O. A. Klochkova, A. L. Kurenkov, K. M. Karimova, B. I. Bursagova, L. S. Namazova-Baranova, A. M. Mamedyarov, L. M. Kuzenkova, I. M. Tardova, I. V. Fal’kovskiy, O. G. Dontzov, M. A. Ryzhenkov, V. A. Zmanovskaya, M. N. Butorina, O. L. Pavlova, N. N. Harlamova, D. M. Dankov, E. V. Levitina, D. A. Popkov, S. O. Ryabykh, S. N. Medvedeva, E. B. Gubina, L. N. Vladykina, V. M. Kenis, T. I. Kiseleva, D. A. Krasavina, O. N. Vasil’eva, A. S. Nosko, V. P. Zykov, V. I. Michnovich, T. A. Belogorova, L. V. Rychkova
Publikováno v:
Педиатрическая фармакология, Vol 13, Iss 3, Pp 259-269 (2016)
Background: The contemporary application of Botulinum toxin A (BTA) in cerebral palsy (CP) implies multilevel injections both in on-label and off-label muscles. However, there is no single international opinion on the effective and safe dosages, targ
Externí odkaz:
https://doaj.org/article/8311b1c0bf284d4290f52f9a2060867b
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 112-123 (2015)
In the Russian Federation, as well as in many countries of the world, several botulinum toxin type A (BTA) drugs are licensed for use as injections; these are biological medicinal products derived from Clostridium botulinum. It is highly important to
Externí odkaz:
https://doaj.org/article/baf069d3bc5b47c6ae06e253221ce578
Autor:
O. A. Klochkova, A. L. Kurenkov, H. M. Karimova, B. I. Bursagova, L. S. Namazova-Baranova, L. M. Kuzenkova, A. M. Mamedyarov, G. M. Dvoryakovskaya
Publikováno v:
Педиатрическая фармакология, Vol 12, Iss 4, Pp 398-406 (2015)
Background. Drooling (sialorrhea) is a complex medical and social problem of patients with cerebral palsy (CP). During the last decade many methods for drooling correction in CP are under active development.Aim: to evaluate the effectiveness and safe
Externí odkaz:
https://doaj.org/article/770af9acea1243cc80322406cca98f16